-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on Evaxion Biotech, Lowers Price Target to $6

Benzinga·02/04/2025 16:19:53
Listen to the news
Lake Street analyst Thomas Flaten maintains Evaxion Biotech (NASDAQ:EVAX) with a Buy and lowers the price target from $35 to $6.